Mychal Wilson ’89 exposed fraud and helped bring about $515 million in settlements between  pharmaceutical giant and state and federal governments
 Every aspiring actor needs a day job, but corrupt sales  representative wasn’t a role Mychal Wilson ’89 was willing to  play.
Every aspiring actor needs a day job, but corrupt sales  representative wasn’t a role Mychal Wilson ’89 was willing to  play.
Instead, he became a vocal whistleblower who helped bring about $515  million in settlements between pharmaceutical giant Bristol-Meyers  Squibb (BMS) and the Unites States Department of Justice as well as 44  state Medicaid programs to resolve fraud allegations made by Wilson and  others.
“It’s scary that the public doesn’t know that someone can walk into a  doctor’s office and bribe him,” Wilson says. “Then you walk in and the  doctor prescribes this medication. And you don’t know why. Why drug B  over drug C? Sometimes because the pharma rep you saw leaving the office  just provided the doctor with a kickback.”
Wilson’s story began  following a stint on Wall Street, as he and David Portlock ’88 set their sights on the independent film industry in Los Angeles. There  Portlock wrote and directed while Wilson acted and executive produced a  highly acclaimed 1996 Sundance Film Festival flick, The Spartans.  Though it had been a success, it lacked one critical element — funding  to become a feature film. In what Wilson describes as a “hard, hard  business,” additional cash flow would be needed to continue infiltrating  the scene, where the friends would team up again for the feature film The  Gristle.
Cue Wilson’s debut into the life of a salesman.
Wilson grasped the opportunity to support his passion, a career in  film, and as time drew on, as an attorney for the entertainment  industry. He spent his days making sales pitches to physicians, his  lunches reading for auditions, and his vacation days filming television  and commercial spots. As he delved further into the acting world, he  found his interests from the past — law and politics — resurfacing,  and he enrolled at Southwestern University School of Law.
But as his legal mind developed, so did tensions at work. Upper  management told Wilson he was a target for termination, claiming his  studies detracted from time for sales. Though Wilson was enrolled in the  evening program and his colleagues were pursuing MBAs, his newly  garnered legal sense, coupled with how vocal he had been about  fraudulent practices in the company, marked him as a potential  liability.
Wilson says that during the early 2000s, “massive amounts” of money  were being spent on doctors – bottles of liquor, gift certificates, golf  sessions, trips to exotic locales, suites at the Staples Center for  Lakers games, preceptorships and consulting agreements — but the  promised “educational component” of these incentives was nothing but a  “sham.” In exchange, doctors were supposed to increase the number of  prescriptions they wrote for the company’s drugs, including ones  reimbursed by Medicare/Medicaid.
“Pressure was put on all reps,” Wilson says. “If you did not recruit a  certain number of doctors to become consultants, you were perceived as  not doing your job. In fact, in some cases if you did not blow out your  monthly budget wining and dining physicians, office staff, pharmacists,  etc., then you were perceived as not a team player.”
Wilson won BMS’ Pinnacle Award for top-ten achievement in sales  despite the fact that his expense reports paled in comparison to his  colleagues’. “I didn’t like playing the game,” he says. “I wasn’t into  it and neither were some physicians whom I have developed and maintained  strong relationships with.”
Wilson continued to be vocal about the fraudulent practices he  witnessed, such as bribing doctors, which would contribute to BMS’  settlement for illegal pricing and marketing of drugs. Additionally, he  amassed a “voluminous amount” of documents — receipts, expense reports,  attendee records, physician consulting agreements, and other fraudulent  documents. These records not only garnered the attention of his  supervisors, but also that of filmmaker Michael Moore, who at the time  was seeking material for his documentary Sicko since he had been  banned from physicians’ offices. Ultimately, Wilson was terminated.
Unknowingly joined by several other BMS employees from around the  country, Wilson filed suit against his former employer on behalf of the  government in what is known as a “Qui Tam” case under the False Claims  Act. This tenet, established by Abraham Lincoln, allows a whistleblower  to bring a case that fraud has been committed against the government,  and in exchange, potentially receive up to 15-25% of the overall  settlement. The catch, however, is that the relator (AKA  “whistleblower”) must be an original source of information and refrain  from public disclosure. The case remains sealed so that only the client,  his or her attorney, and the Department of Justice are aware of its  content, and only if the DOJ decides to subpoena the company does it  learn that it is being investigated but not why. “It is one of the ways  to protect the whistleblower while investigating,” says Wilson.
“It involves this world of secrecy, and a lot of whistleblowers  become isolated,” he adds. “The only people they can really speak to are  their attorneys. You can’t discuss your case because it could blow up  in your face.”
When Wilson brought his case, he did not have a wife or children,  which allowed him to persist through the settlements. However, he says  that many potential whistleblowers remain silent for fear of fallout  such as banishment, bankruptcy or divorce — a heavy price to pay if the  settlement is for naught.
Though now a successful entertainment attorney at his firm,  MindFusion Law LPP — he’s been credited as entertainment attorney  and/or producer’s representative in about 10 films since 2005 — Wilson  is still involved with waging the battle against health care fraud. In  addition to serving as a “vigilante lawyer” for other whistleblowers, he  frequently speaks to members of Capitol Hill to beef up initiatives to  address the fraud committed by pharmaceutical giants.
“After all, fraud against the United States government is a  bipartisan issue and the False Claims Act has recovered billions of  dollars for U.S. taxpayers,” he says. “Of course, these recoveries are  extremely vital in our present economic state and President Obama’s  legislation for health care reform.”
For Wilson, his big case boosted his confidence and desire to fight  for justice.
“Some thought I was crazy and went a little too Hollywood,” he says.  “But in the end I was right. And now, I’m a model of how someone can  really step forward and correct what’s going on in the health care  industry.”